Manuscript citation: bioRxiv: C.V.L. Olson, N. Shariati, N. Procházková, K. Čížek, M. Řehořová, J. Populová, J.T. Rozlivková, S. Wang, B. Ricketts, B. Kučerová, J. Kudláček, B. Straka, P. Jiruška, O. Novák. Dasatinib–Quercetin May Reduce Senescence Markers, Without Senolysis or Seizure Modification, in a Mouse Model of Focal Cortical Dysplasia (2026). bioRxiv; https://doi.org/10.64898/2026.05.19.726138 License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Protocol status: WorkingWe use this protocol and it's working
Created: March 09, 2026
Last Modified: June 08, 2026
Protocol Integer ID: 305437
Keywords: low-molecular-weight compounds, LMW extraction, serum extraction, brain tissue extraction, protein precipitation, cold organic solvent, acetonitrile, methanol, formic acid, LC-MS/MS, liquid chromatography mass spectrometry, internal standard, stable isotope labeling, dasatinib, quercetin, senolytic, molecular weight cutoff, MWCO filtration, sample preparation, mouse serum, mouse brain, pharmacokinetics, tissue homogenization, metabolite extraction, analyte quantitation, weight compounds from mouse serum, liquid chromatography, extraction solvent for all study sample, extraction solvent, tandem mass spectrometry, extraction of low, macromolecules before analysis, extraction, serum, weight compound, brain tissue for quantitation, clarified extract, brain tissue this protocol, macromolecule, extract, protein, brain tissue
Funders Acknowledgements:Ministry of Health of the Czech Republic
Grant ID: NW24-04-00041
National Institute for Neurological Research (Programme EXCELES)
Grant ID: LX22NPO5107
Charles University EXCITE
Grant ID: UNCE24/MED/021
Charles University
Grant ID: PRIMUS/23/MED/011